-
Esperion Therapeutics' (ESPR) Market Outperform Rating Reaffirmed at JMP Securities
Источник: Buzz FX / 11 фев 2025 10:16:12 America/Chicago
Esperion Therapeutics' (ESPR) Market Outperform Rating Reaffirmed at JMP Securities Written by MarketBeat February 11, 2025 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) 's stock had its "market out
Read more...